business
Carl Zeiss Meditec Q2 Earnings Call Highlights
Key takeaways
- Carl Zeiss Meditec Q2 Earnings Call Highlights Market Beat Tue, May 12, 2026 at 5:07 PM GMT+7 7 min read AFX.DE AFX Carl Zeiss Meditec logo Key Points Interested in Carl Zeiss Meditec AG?
- First-half results were weak, with order entry down 5.2% and revenue down 5.7% year over year.
- Ophthalmology was the main pressure point, as revenue fell 6.7% and the EBITA margin dropped to 1.5%.
Carl Zeiss Meditec Q2 Earnings Call Highlights Market Beat Tue, May 12, 2026 at 5:07 PM GMT+7 7 min read AFX.DE AFX Carl Zeiss Meditec logo Key Points Interested in Carl Zeiss Meditec AG? Here are five stocks we like better.
First-half results were weak, with order entry down 5.2% and revenue down 5.7% year over year. Adjusted EBITDA margin also fell sharply to 6.1% from 10.7%, hurt by currency headwinds, product mix, and softer demand in China.
Ophthalmology was the main pressure point, as revenue fell 6.7% and the EBITA margin dropped to 1.5%. The segment was hit by the loss of bifocal intraocular lens sales in China, scrapping of recalled IOLs, and a large write-off tied to the deprioritized Infinite Vision Optics project.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Carl Zeiss Meditec Q2 2026 highlights adjusted EPS beat
Investing.com
Carl Zeiss Meditec first-half earnings halve on currency, IOL headwinds
Investing.com
Earnings call transcript: Sunoco LP Q1 2026 earnings beat expectations
Investing.com
Earnings call transcript: IAC Q1 2026 reveals significant earnings miss
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop